Phil Kitchen
kitchenphil.bsky.social
Phil Kitchen
@kitchenphil.bsky.social
BBSRC Discovery fellow at @AstonUniversity. I use and develop molecular and biophysical tools to study aquaporins, glia, and CNS barriers. Late-diagnosed autistic. he/him
Reposted by Phil Kitchen
We're also collaborating with a colleague at Harwell to use neutrons to investigate lipid exchange between membranes. Lots of protein biochemistry and biophysics. Get in touch if that's your idea of a good time!
March 18, 2025 at 8:20 PM
Could you add me please?
December 6, 2024 at 3:23 AM
Lucas is now on bluesky at @ungerlucas.bsky.social
December 5, 2024 at 3:50 PM
This is (bluesky-less) Lucas Unger's first manuscript from his PhD work, and a big team effort involving members of #TeamAQP across the world. We are keen to get feedback on our study, and urge caution to researchers using AER-270 or TGN-020 in their work!
December 5, 2024 at 3:46 PM
TGN-020 appears to be an allosteric modulator of adenosine receptors, and both compounds modulated mTOR signalling in astrocytes (in opposite directions). These off-target effects mean that existing literature on effects of AER-270 and TGN-020 in in vivo models should be re-evaluated.
December 5, 2024 at 3:46 PM
We further report a variety of off-target effects of these compounds. AER-270 inhibited carbonic anhydrase and NF-kB signalling via IKKB with downstream effects on AQP4 gene expression.
December 5, 2024 at 3:46 PM
We conclude that the Xenopus assay is susceptible to false positive hits. Using a proteomics-based target identification method, we found 30 common targets of TGN-020 and AER-270 in Xenopus oocytes which could plausibly explain this.
December 5, 2024 at 3:46 PM
There are several other examples of “aquaporin-4 inhibitors” in the literature that appear to inhibit aquaporin-4 in the Xenopus assay but not in any other assay system, including acetazolamide, and various antiepileptics and loop diuretics.
December 5, 2024 at 3:46 PM
We then went back to the “gold standard” Xenopus laevis oocyte swelling assay and found apparent inhibitory effects, consistent with the existing literature.
December 5, 2024 at 3:46 PM
We tested AER-270 and TGN-020 using recombinant AQP4 protein reconstituted into proteoliposomes and again found no inhibitory effect.
December 5, 2024 at 3:46 PM
We initially became interested in TGN-020 and AER-270 as positive controls in a screen for novel aquaporin-4 modulators. To our surprise, they were not functional in assays using mammalian cell lines overexpressing aquaporin-4, nor in primary astrocytes.
December 5, 2024 at 3:46 PM